FDA inspection

ANSTO Nuclear Medicine: FDA inspection ending Apr 17, 2019

FDA inspection 1086494 · Voluntary Action Indicated (VAI) · Lucas Heights

Key facts

Inspection ID 1086494
Firm ANSTO Nuclear Medicine
FEI number 3002724726
Address Building 88, New Illawarra Road
City Lucas Heights
Fiscal year 2019
Inspection end date Apr 17, 2019
Classification Voluntary Action Indicated (VAI)
Project area New Drug Evaluation
Product type Drugs

At a glance

  • None Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections